Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AM.ETF PACIF.JAP. (LTF: CP9)
339.84 GBP  UNCHANGED
Last Price  /  Updated: 10:28 AM EDT, May 7, 2013  /  Add to My Watchlist      
View: Quote News
Fund Overview
AM.ETF PACIF.JAP.
Sector
Exchange Traded LTF
Net Assets 81.80M
Inception Date
Related Funds EVY HXD PAF CBE7
Quote
Price 339.84
Volume 0
Last Trade May 07, 10:28am
Change (%)
+0.00 (0.00%)
Prev. Close 339.84
YTD %
+11.22%
Dividend Yield N/A
Performance
YTD
+34.29 (11.22%)
1 Month
-2.02 (-0.59%)
3 Month
+1.65 (0.49%)
6 Month
+54.81 (19.23%)
1 Year
+92.80 (37.56%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
UPDATE 1-Cephalon gets subpoena from U.S. DOJ
September 30, 2011
* Gets subpoena from DOJ regarding drugs Nuvigil, Provigil Read More
from Reuters: Company News
EU mergers and takeovers (Sept 28)
September 28, 2011
BRUSSELS, Sept 28 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: Read More
from Reuters: Company News
Top News
More News
REFILE-UPDATE 1-Valeant offers C$88 mln for Afexa, tops Paladin
September 26, 2011
* Afexa shares jump 16 pct to C$0.87 (Adds share price jump, details) Read More
from Reuters: Company News
Valeant to offer C$88 mln for Afexa, tops Paladin
September 26, 2011
* Valeant offer for C$0.85/share, subject to conditions Read More
from Reuters: Company News
EU mergers and takeovers (Sept 23)
September 23, 2011
BRUSSELS, Sept 23 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: Read More
from Reuters: Company News
Teva offers EU watchdog concessions for Cephalon buy
September 23, 2011
BRUSSELS, Sept 23 (Reuters) - Teva Pharmaceutical Industries Ltd has offered concessions in a bid to ease EU regulatory concerns over its plan to buy U.S. speciality drugmaker Cephalon Inc. , the... Read More
from Reuters: Company News
Cephalon sues Sandoz over Fentora cancer drug
September 16, 2011
Sept 16 (Reuters) - Cephalon Inc on Friday sued Novartis AG's Sandoz drug unit, accusing it of trying to infringe two patents related to its Fentora drug that treats pain in adults who have cancer. Read More
from Reuters: Company News
EU mergers and takeovers (Sept 16)
September 16, 2011
BRUSSELS, Sept 16 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: Read More
from Reuters: Company News
EU mergers and takeovers (Sept 14)
September 14, 2011
BRUSSELS, Sept 14 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: Read More
from Reuters: Company News
UPDATE 2-Valeant tops Paladin with C$76 mln bid for Afexa
August 30, 2011
* Deal requires 66 2/3 shares to be tendered (Adds details, Valeant CEO's comment) Read More
from Reuters: Company News
EU mergers and takeovers (Aug 29)
August 29, 2011
BRUSSELS, Aug 29 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: Read More
from Reuters: Company News
UPDATE 3-Generic threat to Valeant drug sends shares reeling
August 04, 2011
* Company raises earnings forecast, backs revenue forecast Read More
from Reuters: Company News
UPDATE 1-Cephalon quarterly profit falls short of estimates
August 02, 2011
LOS ANGELES, Aug 2 (Reuters) - Drugmaker Cephalon Inc , which is being acquired by Teva Pharmaceutical Industries Ltd , reported lower-than-expected quarterly earnings as revenue fell short of Wall... Read More
from Reuters: Company News
UPDATE 5-Meda shares jump on Valeant bid speculation
July 27, 2011
* Valeant shares rise 2 percent (Adds details on Valeant) Read More
from Reuters: Company News
UPDATE 3-Valeant makes approach for drugmaker Meda
July 26, 2011
* Deal for Meda could be more than $4 billion (Recasts, adds new sourcing) Read More
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here